Addressing a serious electrical disorder of the heart, Long QT Syndrome, Mayo Clinic is developing a potentially life-saving device for early detection.
There are several forms of Long QT, ranging in severity and cause. Some known causes are:
- More than 100 drugs approved by the Food and Drug Administration (FDA).
- Genetics, including congenital long QT syndrome.
- Many systemic diseases, including even SARS-CoV-2-mediated COVID-19.
Original article
Mayo Clinic research yields breakthrough in mobile determination of QT prolongation
MAYO CLINIC
ROCHESTER, Minn. — Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. This research has yielded a breakthrough in determining the health of the electrical recharging system in a patient’s heart. The researchers determined that a smartphone-enabled mobile EKG device can rapidly and accurately determine a patient’s QTc, thereby identifying patients at risk of sudden cardiac death from congenital long QT syndrome (LQTS) or drug-induced QT prolongation.
Read the entire article
Share this article
Facebook
Twitter
LinkedIn
Kulman, LLC © All Rights Reserved 2020